Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Breast cancer diagnostics company announces distribution agreement
June 16th, 2005
Neothermia Corporation and Carbon Medical Technologies (CMT) announced a multiyear distribution agreement whereby Neothermia Corporation will market and sell CMT's U.S. Food and Drug Administration (FDA)-cleared BiomarC, a radiopaque soft tissue marking device that can help simplify and enhance both new and traditional approaches to imaging and diagnosing breast cancer. Under the agreement, Neothermia Corporation will market BiomarC to radiologists at imaging clinics and medical centers throughout the United States. BiomarC will be marketed and distributed along with Neothermia Corporation's en-bloc device, a minimally invasive breast biopsy system that has been shown...
Source: Women's Health Weekly (2005-06-16)
|
